Nuril Farid Abshori

Nuril Farid Abshori

Auto-generated profile, based on publicly available information

Nuril Farid Abshori

Professional Medical Doctor Program, Faculty of Medicine and Health Sciences, Maulana Malik Ibrahim Islamic State University, Malang, Indonesia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2025 in Journal of Agriculture and Food Research
Verified
Journal Article
Open access
KLKiki Lukman
Kiki Lukman
PNprapanca nugraha
prapanca nugraha
NTNurpudji Astuti Taslim
Nurpudji Astuti Taslim
NANuril Farid Abshori
Nuril Farid Abshori
EWElvan Wiyarta
Elvan Wiyarta
Fahrul NurkolisFahrul Nurkolis
Fahrul Nurkolis

3 September 2025 in Narra Review
Verified
Journal Article
Open access
PDF file
NANuril F. Abshori
Nuril F. Abshori
RMRaihan R. Mardliyyah
Raihan R. Mardliyyah
UNUfada A. Nadlifah
Ufada A. Nadlifah
AAAchmad Z. Arif
Achmad Z. Arif
IAIwal R. Ahdi
Iwal R. Ahdi
Hepatocellular carcinoma (HCC) is the most common form of liver cancer, accounting for approximately 75% of all liver cancer cases, and has the worst prognosis. Current therapies for HCC remain suboptimal, with sorafenib therapy only prolonging survival by 2–3 months, combination therapies often cause adverse events (AEs), and drug resistance remains a challenge. To address these issues, mesoporous silica nanoparticles (MSNs) have been investigated as potential drug delivery systems due to their high surface area, tunable pore size, and ability to enhance drug stability and release. The aim of this study was to explore the potential of MSN-based drug delivery systems for improving HCC therapy. This study employed a systematic review design with a computerized search of six databases up to June 15, 2023. Inclusion criteria were: (1) in vivo studies with mouse subjects, (2) subjects with HCC receiving therapy, (3) therapy conjugated with or coated by MSNs, and (4) evaluation of therapeutic effectiveness based on statistical outcomes. Exclusion criteria included irrelevant titles or abstracts, incomplete texts, and non-original research such as reviews, case reports, and conference abstracts. A total of 1,844 studies were screened, and eight studies met the eligibility criteria for analysis. The results indicated that MSN-based drug delivery systems significantly improved therapeutic outcomes in HCC-bearing mice by enhancing drug penetration, reducing tumor size, and minimizing systemic toxicity compared to conventional formulations. These findings suggest that MSNs hold promise as an advanced drug delivery platform for HCC therapy. However, further preclinical and clinical studies are required before translation into clinical practice.

22 December 2025 in Narra X
Verified
Journal Article
Open access
PDF file
IQIntan Qanita
Intan Qanita
NANuril F. Abshori
Nuril F. Abshori
DRDerren David Rampengan
Derren David Rampengan
RRRoy Ramadhan
Roy Ramadhan
AAArga S. Adji
Arga S. Adji
SASami A. Al-Dubai
Sami A. Al-Dubai
Indonesia continues to face a double burden of malnutrition, characterized by persistent undernutrition and a growing prevalence of overweight among children. Although urban children typically show lower rates of stunting and underweight, emerging evidence indicates rising obesity due to unhealthy behavior. At the same time, national indicators may mask substantial heterogeneity at the provincial and district levels. This study aimed to compare urban–rural disparities in child nutrition and maternal care at the national level and examines intra-provincial variation that may be obscured by aggregated statistics. An ecological analysis was conducted using data from the 2024 Indonesian Nutritional Status Survey. Urban–rural differences were evaluated using odds ratios (OR) and Chi-square tests. Sub-provincial analyses were undertaken in selected districts of Central Java and South Sulawesi to assess patterns of variation across smaller administrative units. At the national level, urban children exhibited lower odds of severe underweight (OR: 0.78; 95%CI: 0.75–0.81), underweight (OR: 0.82; 95%CI: 0.80–0.84), and stunting (OR: 0.77; 95%CI: 0.75–0.78). In contrast, they had higher odds of being at risk of overweight (OR: 1.35; 95%CI: 1.31–1.40) and of consuming unhealthy foods (OR: 1.22; 95%CI: 1.19–1.25). Rural areas showed poorer dietary diversity and lower coverage of antenatal care. District-level analyses revealed marked contrasts, where in Central Java, Magelang Municipality had lower odds of severe underweight than Surakarta and Tegal Municipalities. Meanwhile, in South Sulawesi, Makassar Municipality performed better than Pare-pare Municipality but still lagged behind Tana Toraja. These intra-provincial patterns suggest that urban residence does not uniformly confer nutritional advantage. Significant inequities persist not only between urban and rural populations but also across districts within the same province. Smaller cities with stronger health service access, such as Magelang Municipality, tend to show better child nutrition outcomes.

30 June 2026 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
NANuril F Abshori
Nuril F Abshori
Muhammad IqhrammullahMuhammad Iqhrammullah
Muhammad Iqhrammullah
RMRaihan R Mardliyyah
Raihan R Mardliyyah
RNR Moch S S S Negara
R Moch S S S Negara
AAAchmad Z Arif
Achmad Z Arif
Muhammad HabiburrahmanMuhammad Habiburrahman
Muhammad Habiburrahman
Introduction: Timely identification of sepsis patients at elevated risk for in-hospital mortality or prolonged hospitalization remains a clinical imperative. This study aimed to assess the prognostic utility of two readily available hematological biomarkers, namely the neutrophil-to-lymphocyte count ratio (NLCR) and platelet-to-lymphocyte count ratio (PLCR), for their association with mortality and length of stay (LOS) among sepsis patients, including high-risk subgroups with acute kidney injury (AKI) or type 2 diabetes mellitus (T2DM). Methodology: This retrospective 1-year cohort study included 202 adult sepsis patients. NLCR and PLCR were derived from admission complete blood counts. Receiver operating characteristic (ROC) curve analysis was used to evaluate discriminative performance, with optimal thresholds determined using Youden’s index. Kaplan–Meier and log-rank tests assessed survival differences, while LOS comparisons were analyzed using Mann–Whitney and Chi-square tests. Results: NLCR demonstrated limited overall prognostic value for mortality (AUC 0.560; sensitivity 53.68%; specificity 63.55%) but showed improved discrimination in patients with T2DM (AUC 0.603). PLCR was not associated with mortality in any subgroup (AUCs: 0.438–0.539). Diabetic patients with low NLCR had significantly higher survival (62.4% vs. 32.8%; p = 0.039). No significant survival differences were observed in the overall or AKI cohorts. Both NLCR and PLCR had poor association with LOS (AUC < 0.55). However, AKI patients with elevated NLCR had significantly prolonged hospitalization (11.5 ± 4.9 vs. 7.83 ± 4.5 days; p = 0.039). PLCR was not significantly associated with LOS. Conclusions: NLCR may provide modest, preliminary prognostic value in specific sepsis subgroups, particularly those with T2DM or AKI, and may serve as a low-cost adjunct for early risk stratification.